Inhaler component

Abstract
The invention relates to an inhaler component for forming a vapor-air mixture and/or condensation aerosol by vaporizing a liquid material and optionally condensing the vapor formed, including: a heating element for vaporizing a portion of the liquid material; a wick for automatically supplying the liquid material to the heating element, wherein the wick includes at least two end sections arranged apart from each other; a first capillary gap for automatically supplying the liquid material to the wick, wherein a first end section of the wick projects into the first capillary gap. In order that the heating element can be supplied more quickly and more reliably with the liquid material, a second capillary gap is provided, which receives therein the second end section of the wick.
Description

The invention relates to an inhaler component for the formation of a vapour-air mixture or/and of a condensation aerosol by evaporating a liquid material and, if necessary, condensing the vapour formed, comprising: a heating element for the evaporation of a portion of the liquid material; a wick for the automatic supply of the heating element with the liquid material, the said wick having at least two end sections arranged at a distance from each other; a first capillary gap for the automatic supply of the wick with the liquid material, wherein a first end section of the wick extends into the first capillary gap.


Definition of terms: In the present patent application the term “inhaler” refers to medical as well as non-medical inhalers. The term refers furthermore to inhalers for the administration of drugs and materials which are not declared as drugs. The term refers, in addition, to smoking articles and cigarette substitutes, such as those in European patent class A24F47/00B, for example, as far as these are intended to supply the user with a vapour-air mixture or/and a condensation aerosol. The term “inhaler” also implies no restrictions on how the vapour-air mixture or/and condensation aerosol formed is supplied to the user or his body. The vapour-air mixture or/and condensation aerosol can be inhaled into the lungs or, in addition, only supplied to the oral cavity—without inhalation into the lungs.


“Capillary gap” means any gap which causes liquid transport solely on the basis of the capillary action of its confining walls. Wicks, wrapped wicks or channels filled with wick material are not capillary gaps.


WO 2010/045671 (Helmut Buchberger) describes an inhaler component for the intermittent, inhalation or pull-synchronous formation of a vapour-air mixture or/and condensation aerosol, consisting of (FIGS. 9 to 12 and FIGS. 17 to 18) a housing 3, a chamber 21 provided in the housing 3, an air intake opening 26 for the supply of air from the environment into the chamber 21 and an electric heating element for the evaporation of a portion of a liquid material 16, in which case the vapour formed mixes in the chamber 21 with the air supplied by the air intake opening 26 and the vapour-air mixture or/and condensation aerosol is or are formed. Furthermore, the inhaler component comprises a wick with a capillary structure, which wick forms with the heating element a laminar composite 22 and automatically resupplies the heating element with the liquid material 16 after evaporation. At least one heated section of the composite 22 is arranged without contact in the chamber 21 and the capillary structure of the wick lies exposed to a large extent in the said section at least on one side 24 of the laminar composite. One end of the laminar composite 22 projects into a capillary gap 41, which is coupled or is capable of being coupled by capillary to a liquid container 4 containing the liquid material 16. The capillary gap 41 draws the liquid material 16 from the liquid container 4 and conveys it to the wick.


After evaporation or inhalation the user of the inhaler component must observe a waiting period, during which the liquid material 16 can again completely infiltrate the wick. Evaporations before the expiration of the waiting period can lead to various disadvantageous consequences, for example a decrease in the given aerosol quantity or/and a local overheating of the wick, possibly associated with a decomposition of the liquid material and a degradation of the organoleptic characteristics of the vapour-air mixture or aerosol formed. In prototypes based on highly diluted ethanol or/and aqueous nicotine solutions, it was possible to obtain complete infiltration of the wick within 10 s. If the inhaler component is used as a cigarette replacement, then a waiting period of 10 s may be acceptable for many smokers; for some smokers, however, it may be too long. Furthermore, with the same prototypes it has been shown that even when the waiting period mentioned is adhered to, disturbances of the infiltration can occur. These disturbances rarely arise, but can lead to the same disadvantageous consequences as described above. The disturbances are characterized by an unsatisfactory wetting of the capillary structure of the wick by the liquid material and occur preferably locally, in regions of the wick which are peripheral in relation to the capillary gap.


The object of the invention is to remedy the aforementioned disadvantages of the arrangement known from the state of the art. More particularly, it is the object of the invention to design an inhaler component of the type described in the preamble in such a way that the wick is infiltrated with the liquid material as rapidly as possible and no unpleasantly long waiting periods occur. Local disturbances of the infiltration are likewise to be avoided. All of this is to be achieved, if possible, without additional structural outlay. The production costs of the inhaler component should likewise not be increased.


This object is achieved by the characterizing features of claim 1. Accordingly, the inhaler component is provided with a second capillary gap, which holds the second end section of the wick. The wick is thus supplied with the liquid material from two sides. As a result, the waiting period for complete infiltration of the wick can be at least halved as compared with a conventional one-sided supply. If one considers that the infiltration of the wick with the liquid material takes place in a degressive-proportional manner, i.e. comparatively rapidly at the beginning and then more slowly, then it becomes clear that the waiting period for the complete infiltration of the wick by the arrangement according to the invention can be shortened by significantly more than 50%. Similarly advantageous effects result regarding the security of supply of the wick: the particularly endangered regions of the wick on the periphery in relation to the first capillary gap can now be reliably supplied with the liquid material over a short distance from the second capillary gap.


In a preferred embodiment of the invention it is provided that the first and second capillary gaps are connected to each other by a third capillary gap. The first and second capillary gaps thus communicate with each other via the third capillary gap. Thus any uneven supply of the first and second capillary gap with the liquid material can be equalized, and the security of supply to the wick further improved.


It is further provided according to the invention that one of the capillary gaps is coupled or capable of being coupled by capillary to a liquid container containing the liquid material. This capillary gap can for example be the first capillary gap. In this case the second capillary gap would be supplied with the liquid material exclusively via the third capillary gap. In addition, it could alternatively be provided that the third capillary gap is coupled or capable of being coupled by capillary to the liquid container. In this case the first and second capillary gaps would be supplied with the liquid material via the third capillary gap.


Conditions which are particularly simple structurally result if all the capillary gaps are situated in a common plane. A further structural simplification is obtained by all the capillary gaps being formed by a board, preferably a printed circuit board, and an upper section mounted on the board. In this case only two components are required to form all the capillary gaps.


In a first variant of embodiment the upper section has, according to the invention, a recess facing the board. The recess forms the capillary gaps in co-operation with the surface of the board, the depth of the recess setting the width of the capillary gaps. It is particularly advantageous for the recess to be bounded at least locally by one or more ventilation grooves. The ventilation grooves have the advantageous effect that the liquid material stored in the capillary gaps can be used more effectively as buffer volumes.


In a second alternative variant of embodiment the upper section is mounted on the end sections of the wick. The end sections of the wick act in this case as spacers which set the width of the capillary gaps. In this alternative variant of embodiment too, the upper section would be considered as being “mounted on the board”, even if the two components do not touch each other directly.


The board is preferably designed in the form of a printed circuit board and it serves as such for supplying electrical energy to the—in this case—electric heating element. In this case it is particularly advantageous for the printed circuit board to be designed in the form of a multiple-layer, so-called multilayer, printed circuit board. As a result, the conductive strips supplying the electric current can in this case be concentrated in layers which do not affect the capillary gaps. In addition, more complex arrangements of conductive strips can also be implemented by means of multilayer printed circuit boards, a circumstance which proves advantageous at the latest when a plurality of electric heating elements are provided, and the heating elements are to be actuated independently of one another. Finally, on account of the multiple-layer arrangement of their conductive strips, multilayer printed circuit boards allow comparatively high electric currents to be transmitted.


In a further arrangement of the invention it is provided that the first capillary gap is coupled or is capable of being coupled to a first liquid container containing the liquid material and the second capillary gap is coupled or is capable of being coupled to a second liquid container containing the liquid material. By providing two liquid containers essentially independent of each other the security of supply of the wick with the liquid material can once again be increased.


Expedient and advantageous embodiments of the invention are illustrated in the drawings and are explained in greater detail in the following description.





IN THE DRAWINGS


FIG. 1A shows a bottom view of an exemplary inhaler component according to the invention;



FIG. 1B shows a front view of an exemplary inhaler component according to the invention;



FIG. 1C shows a top view of an exemplary inhaler component according to the invention;



FIG. 2 is a longitudinal section through the inhaler component according to FIG. 1B at the level of the laminar composite;



FIG. 3 is a cutaway view of the inhaler component along the line A-A in FIG. 2;



FIG. 4 shows the detail from FIG. 3 in an enlarged view;



FIG. 5 is a cutaway view of the inhaler component along the line B-B in FIG. 2;



FIG. 6 shows the printed circuit board including a laminar composite;



FIG. 7 shows the printed circuit board including a laminar composite joined to the upper section forming the capillary gaps;



FIG. 8A shows a view of the upper section forming the capillary gaps;



FIG. 8B shows a further view of the upper section forming the capillary gaps, with the capillary gaps and recess visible;



FIG. 9 shows an inhaler component according to the invention in an alternative embodiment in a view similar to FIG. 2.






FIGS. 1A through 1C show multiple views of a first embodiment of an inhaler component according to the invention. The inhaler component in the specific example is designed in the form of an interchangeable part of the inhaler and is capable of being coupled via a snap connection 1 to a reusable inhaler part (not further shown). The inhaler component together with the reusable inhaler part forms the inhaler. The inhaler component consists of a housing 2 and further comprises a mouthpiece 3, by way of which the user of the inhaler draws the vapour-air mixture or/and the condensation aerosol.



FIGS. 2 to 5 provide further information about the internal structure of the inhaler component. Thus a carrier plate 4, which is preferably designed as a printed circuit board, is located in the housing 2. The printed circuit board 4 carries a laminar composite 5. The laminar composite 5 consists of a wick 7 and an electric heating element 6, which are connected to each other in a laminar manner or integrated one into the other. The laminar composite 5 can be formed for example by a metal foil with metal fabric layers sintered on it. The laminar composite 5 can alternatively also consist of an open-pored metal foam. The open-pored capillary structure of the fabric layers sintered onto the metal foil or the metal foam forms the wick 7 and the electrical resistance of the metal forms the heating element 6. Suitable metallic resistance materials are, for example, high-grade steels such as AISI 304 or AISI 316 as well as heat-conducting alloys, in particular NiCr alloys.


The wick 7 and the laminar composite 5 containing it have two end sections 7a and 7b arranged at a distance from each other. The laminar composite 5 is mounted with these end sections on the printed circuit board 4. The laminar composite 5 is furthermore electrically contacted in the region of the end sections 7a and 7b on conductive strips of the printed circuit board 4. The electrical contacting of the laminar composite 5 or the resistance heating element 6 thereof mat, for example, consist of an adhesive joint by means of an electrically conducting adhesive, for example, by means of a silver-containing adhesive based on epoxide. The printed circuit board 4 projects from the outside surface of the housing 2 in the form of two plug contacts 8a and 8b. The two plug contacts 8a and 8b serve to introduce the electrical energy into the inhaler component. The electrical energy is supplied to the electrical resistance heating element 6 via conductive strips of the printed circuit board 4. The printed circuit board 4 is preferably designed in the form of a multiple-layer, so-called multilayer, printed circuit board. The conductive strips are thus present in several layers. The advantages of this special type of printed circuit board have already been described above. The electrical energy is preferably drawn from the reusable inhaler part. For this purpose the reusable inhaler part contains a battery and an electrical control circuit for controlling the energy supply.


An upper section 9 having a recess or depression 10 is placed flat on the printed circuit board 4—see FIGS. 3 to 8B. The recess 10 is shown as a black area in FIG. 8B and has a depth of typically 0.2 mm. The recess 19 faces the printed circuit board 4 and, in conjunction with the surface thereof, forms a capillary gap. The capillary gap is shown diagrammatically in FIG. 2 as a black area and consists of three sections: a first capillary gap 11a, into which the laminar composite 5 or wick 7 with its end section 7a projects; a second capillary gap 11b, into which the laminar composite 5 or wick 7 with its end section 7b projects; and a third capillary gap 11c, which connects the first capillary gap 11a to the second capillary gap 11b. The first capillary gap 11a is connected to the liquid container 12 formed by the housing 2 or arranged in it. The liquid container 12 stores a liquid material 13. The capillary forces in the capillary gap 11a pull the liquid material 13 from the liquid container 12 into the capillary gap 11a. The liquid material 13 first reaches the end section 7a of the laminar composite 5.


There the liquid material 13 moistens the capillary structure of the wick 7, after which the wick 7 can be further infiltrated from this side with liquid material 13. In parallel with this the liquid material 13 flows into the capillary gap 11c and finally arrives by way of the latter at the capillary gap 11b, where in the end section 7b it again moistens the capillary structure of the laminar composite 5 or the wick 7. The wick 7 is thus infiltrated from two sides with the liquid material 13. Since the flow resistance of the capillary gaps is substantially lower than the flow resistance of the wick 7, the infiltration of the wick 7 takes place at almost the same time or symmetrically on both sides. Compared with arrangements with only one-sided supply of the wick 7 (see WO 2010/045671) the infiltration time can be substantially reduced.


After the wick 7 or laminar composite 5 has been completely infiltrated with the liquid material 13, the electrical energy can be supplied to the electrical resistance heating element 6 by way of the conductive strips of the printed circuit board 4 and the liquid material 13 evaporated. TO ensure as far as possible that the conductive strips do not affect the capillary gaps, it is advantageous if the conductive strips are arranged primarily on the back of the printed circuit board 4 and, if necessary, in intermediate layers (multilayer printed circuit board), and the individual conductive strips interconnected appropriately according to the state of the art by means of so-called plated-through holes. The vapour released is mixed in a chamber 14 provided in the housing 2 with the air supplied from the environment through an air intake opening 15 (see FIGS. 3 to 5) and forms the vapour-air mixture or/and condensation aerosol, which can then be transferred to a user via the mouthpiece 3.


In accordance with FIGS. 8A and 8B, the recess 10 in the upper section 9 is bounded in the region of the first capillary gap 11a by a first ventilation groove 16a and in the region of the second capillary gap 11b by a second ventilation groove 16b. In FIG. 2 the ventilation grooves 16a and 16b are represented diagrammatically as broken lines and in FIG. 5 are shown in cross-section. The ventilation groove 16a extends up to the liquid container 12 and ensures that each volume of liquid material 13 removed from the liquid container 12 is replaced by an equivalent volume of air. The ventilation slots 16a and 16b draw in the air via ventilation holes 17a and 17b which are formed by the upper section 9 and which for their part are connected to the chamber 14 via connecting channels 18a and 18b formed by the housing 2. The connecting channels 18a and 18b are shown diagrammatically in FIG. 7 as broken lines. The outlet of the connecting channel 18a into the chamber 14 is shown in FIG. 4.


In principle, all known printed circuit board materials are suitable as the material for the printed circuit board 4, in particular the material types FR1 to FR5. The upper section 9 is added to the printed circuit board 4 by adhesive bonding and likewise consists preferably of a plastic. It is important that the surfaces of the printed circuit board 4 as well as of the upper section 9 are well moistened by the liquid material 13. It is preferable for highly diluted ethanol or/and aqueous solutions to be used as the liquid material 13, in which the actual active substances, aerosol-forming materials, flavourings, as well as, if necessary, further ancillary materials are dissolved or/and emulsified. The wettability as well as the adhesion of the plastics can be substantially improved by surface activation, for example by hydrophilization by means of plasma polymerization (the company Diener electronic GmbH+Co. KG, www.plasma.de).



FIG. 9 shows an alternative embodiment of the inhaler component according to the invention. This embodiment differs from the arrangement according to FIG. 2 essentially in that a second liquid container 12b containing the liquid material 13 is provided, which is coupled or is capable of being coupled to the second capillary gap 11b. If a disturbance of the liquid supply occurs in the first supply path (liquid container 12a and capillary gap 11a), then the laminar composite 5 or the wick 7 thereof can still be adequately supplied with liquid material 13 via the second supply path (liquid container 12b, capillary gap 11b and, if necessary, capillary gap 11c).


Still further components of the inhaler component are briefly described below. Even if these components are not directly relevant to the invention, their description nevertheless contributes to a better understanding of the function of the inhaler component according to the invention as a whole and ensures the workability of the invention still more certainly: as shown in FIG. 2, for example, the liquid container 12 has a valve-like, openable catch 19 on a front face. The openable catch 19 seals the liquid container 12 hermetically off from the exterior in its closed position. Only after opening the openable catch 19 can the liquid material 13 moisten the capillary gap 11a and then, through the action of capillary forces in the capillary gap, penetrate further to the laminar composite 5 and finally infiltrate the wick 7 of the laminar composite 5. The openable catch 19 is opened with the aid of a pin 20 mounted in the housing 2 in an axially adjustable manner (FIG. 3 and FIG. 5). A first end of the pin 20 is directed towards the openable catch 19. A second end extends from the outer surface of the housing 2 like an extension with the catch 19 still closed. The second end of the pin 20 is connected to the reusable inhaler part in a tappet-like operating condition. In the course of the coupling of the inhaler component with the reusable inhaler part the pin 20 is shifted into the housing 2, as a result of which the first end of the pin 20 presses against the openable catch 19. The openable catch 19 has a material weakening around its periphery which is dimensioned in such a way that when pressure is applied by the pin 20 it tears like a pre-determined breaking point over a substantial region of its periphery, but forms a hinge on one side. In this way the openable catch 19 is caused to open like a flap.



FIGS. 2 to 5 further show a condensate-binding device arranged in the chamber 14 consisting of two open-pored, absorbent sponges 21a and 21b. The sponges 21a and 21b absorb into their pores condensate deposits formed from the vapour phase and prevent freely mobile accumulations of condensate from forming in the inhaler component, in particular in the chamber 14, which could impair the function of the inhaler component and, in addition, could represent a risk for the user and the environment, if these accumulations contained drug residues or poisons such as nicotine. The two sponges 21a and 21b to a large extent line the inner walls of the chamber 14, where the sponge 21a extends up to the outlet of the air intake opening 15. In this way the condensate deposits should be prevented from reaching the relatively narrow slot-shaped air intake opening 15, as a result of which the air flow could be obstructed. In an alternative arrangement the air intake opening 15 could also be formed directly by the sponges 21a and 21b. The sponges 21a and 21b preferably consist of fine-pored, highly porous fibre composites. The company Filtrona Richmond Inc., www.filtronaporoustechnologies.com, specializes in the production of such fibre composites, in which both triacetin-bonded cellulose acetate fibres and thermally bonded polyolefin and polyester fibres are used.


As shown in FIGS. 2 to 3, a cooler 22 is provided downstream of the sponges 21a and 21b, which in the specific embodiment is integrated into the preferably interchangeable mouthpiece 3 and consists of a porous wadding 23, through the pores of which the vapour-air mixture or/and condensation aerosol formed flow. The cooler 22 cools the vapour-air mixture or/and condensation aerosol flowing through it and during this withdraws still further condensate from it. In this way the organoleptic characteristics of the vapour-air mixture or/and condensation aerosol taken up by the user can be significantly improved. The wadding 23 can consist for example of a tobacco filling. Such a tobacco filling additionally produces a flavouring of the vapour-air mixture or condensation aerosol flowing through it and is particularly desirable if the liquid material 13 contains nicotine.


Finally, it should be pointed out that the invention is naturally not limited to a laminar composite 5 in accordance with the embodiments just described. The composite could just as well have a linear format.


Furthermore, the composite could also be formed from a plurality of composites or composite sections arranged next to one another, where it is immaterial how the individual composites or composite sections are electrically interconnected to one another. In this connection it should be noted that by means of the multilayer printed circuit board 4 according to the invention both series connections and parallel connections as well as more complex wiring and actuation arrangements can be effected. Finally, the invention also covers devices in which the heating element is arranged separate from the wick. For example, the wick could be formed as a laminate and the heating energy transferred to the wick by electromagnetic waves, in particular radiant heat or microwaves.


LIST OF REFERENCES


1 snap connection



2 housing



3 mouthpiece



4 carrier plate, printed circuit board



5 laminar composite



6 heating element, resistance heating element



7 wick



7
a, 7b end sections of the wick or composite



8
a, 8b plug contacts



9 upper section



10 recess



11
a first capillary gap



11
b second capillary gap



11
c third capillary gap



12 liquid container



12
a first liquid container



12
b second liquid container



13 liquid material



14 chamber



15 air intake opening



16
a, 16b ventilation slots



17
a, 17b ventilation holes



18
a, 18b connecting channels



19 openable catch



20 pin



21
a, 21b sponges



22 cooler



23 wadding

Claims
  • 1. An inhaler component comprising: a heating element configured to evaporate a portion of a liquid material;a wick configured to automatically supply the liquid material to the heating element; anda capillary gap configured to automatically supply the wick with the liquid material,wherein the wick has at least two end sections arranged at a distance from one another, and wherein a first end section of the at least two end sections of the wick extends into the capillary gap.
  • 2. The inhaler component according to claim 1, wherein the capillary gap is further configured to automatically resupply the wick with the liquid material after evaporation.
  • 3. The inhaler component according to claim 1, further comprising a laminar composite including the heating element and the wick, and configured such that liquid in the capillary gap is transferred to the wick via an end section of the laminar composite.
  • 4. The inhaler component according to claim 1, wherein the at least two end sections of the wick include the first end section and a second end section, and further the wick includes an intermediate section between the first end section and the second end section, the capillary gap configured to supply the liquid material to at least a portion of at least one of the first end section, the second end section, and the intermediate section.
  • 5. The inhaler component according to claim 1, wherein confining walls of the capillary gap are a board and an upper section mounted on the board.
  • 6. The inhaler component according to claim 5, wherein the upper section has a recess facing the board.
  • 7. The inhaler component according to claim 6, wherein the recess is bounded by at least one ventilation slot.
  • 8. The inhaler component according to claim 5, wherein the board is a printed circuit board.
  • 9. The inhaler component according to claim 8, wherein the printed circuit board is a multilayer printed circuit board.
  • 10. An inhaler comprising: an inhaler component, including: a heating element configured to evaporate a portion of a liquid material;a wick configured to automatically supply the liquid material to the heating element; anda capillary gap configured to automatically supply the wick with the liquid material,wherein the wick has at least two end sections arranged at a distance from one another, and wherein a first end section of the at least two end sections of the wick extends into the capillary gap.
  • 11. The inhaler according to claim 10, wherein the capillary gap is further configured to automatically resupply the wick with the liquid material after evaporation.
  • 12. The inhaler according to claim 10, further comprising a laminar composite including the heating element and the wick, and configured such that liquid in the capillary gap is transferred to the wick via an end section of the laminar composite.
  • 13. The inhaler according to claim 10, wherein the at least two end sections of the wick include the first end section and a second end section, and further the wick includes an intermediate section between the first end section and the second end section, the capillary gap configured to supply the liquid material to at least a portion of at least one of the first end section, the second end section, and the intermediate section.
  • 14. The inhaler according to claim 10, wherein confining walls of the capillary gap are a board and an upper section mounted on the board.
  • 15. The inhaler according to claim 14, wherein the upper section has a recess facing the board.
  • 16. The inhaler according to claim 15, wherein the recess is bounded by at least one ventilation slot.
  • 17. The inhaler according to claim 14, wherein the board is a printed circuit board.
  • 18. The inhaler according to claim 17, wherein the printed circuit board is a multilayer printed circuit board.
  • 19. The inhaler according to claim 12, wherein the end section of the laminar composite comprises an electrical contact.
  • 20. An inhaler component comprising: an electric heating element configured to evaporate a portion of a liquid material;a wick configured to automatically supply the liquid material to the heating element; anda capillary gap configured to automatically supply the wick with the liquid material,wherein the wick and the electric heating element are integrated into one another and connected in a laminar manner, wherein the wick has at least two end sections arranged at a distance from one another, and wherein a first end section of the at least two end sections of the wick extends into the capillary gap.
Priority Claims (2)
Number Date Country Kind
A 187/2011 Feb 2011 AT national
A 1095-2011 Jul 2011 AT national
Parent Case Info

This application is a Continuation of, and hereby claims priority under 35 U.S.C. § 120 to, U.S. patent application Ser. No. 13/984,512, filed Aug. 29, 2013 and entitled “Inhaler Component,” which is the National Stage of International Application No. PCT/AT2012/000017, filed Feb. 2, 2012, which in turn claims priority to Austrian Patent Application No. A187/2011, filed Feb. 11, 2011, and to Austrian Patent Application No. A1095/2011, filed Jul. 27, 2011. The entire contents of the aforementioned applications are herein expressly incorporated by reference.

US Referenced Citations (135)
Number Name Date Kind
2057353 Whittemore, Jr. Oct 1936 A
2809634 Murai Oct 1957 A
3111396 Ball Nov 1963 A
3402724 Blount Sep 1968 A
3431393 Katsuda Mar 1969 A
3433632 Elbert et al. Mar 1969 A
3521643 Toth Jul 1970 A
3804100 Fariello Apr 1974 A
3964902 Fletcher Jun 1976 A
4009713 Simmons et al. Mar 1977 A
4031906 Knapp Jun 1977 A
4094119 Sullivan Jun 1978 A
4145001 Weyenberg et al. Mar 1979 A
4161283 Hyman Jul 1979 A
4193513 Bull, Jr. Mar 1980 A
4503851 Braunroth et al. Mar 1985 A
4588976 Jaselli May 1986 A
4676237 Wood et al. Jun 1987 A
4735217 Gerth et al. Apr 1988 A
4830028 Lawson May 1989 A
4848374 Chard et al. Jul 1989 A
4885129 Leonard Dec 1989 A
4917301 Munteanu Apr 1990 A
4922901 Brooks et al. May 1990 A
4947874 Brooks et al. Aug 1990 A
4947875 Brooks et al. Aug 1990 A
4978814 Honour Dec 1990 A
5027837 Clearman Jul 1991 A
5046514 Bolt Sep 1991 A
5060671 Counts et al. Oct 1991 A
5095647 Zobele Mar 1992 A
5095921 Losee et al. Mar 1992 A
5099861 Clearman Mar 1992 A
5121881 Lembeck Jun 1992 A
5167242 Turner et al. Dec 1992 A
5179966 Losee et al. Jan 1993 A
5247947 Clearman et al. Sep 1993 A
5322075 Deevi et al. Jun 1994 A
5388574 Ingebrethsen Feb 1995 A
5390864 Alexander Feb 1995 A
5479948 Counts Jan 1996 A
5497792 Prasad et al. Mar 1996 A
5501236 Hill et al. Mar 1996 A
5505214 Collins et al. Apr 1996 A
5540241 Kim Jul 1996 A
5553791 Alexander Sep 1996 A
5636787 Gowhari Jun 1997 A
5649554 Sprinkel et al. Jul 1997 A
5666977 Higgins et al. Sep 1997 A
5692291 Deevi Dec 1997 A
5743251 Howell Apr 1998 A
5865185 Collins et al. Feb 1999 A
6095505 Miller Aug 2000 A
6155268 Takeuchi Dec 2000 A
6275650 Lambert Aug 2001 B1
6652804 Neumann et al. Nov 2003 B1
6681998 Sharpe Jan 2004 B2
6701921 Sprinkel Mar 2004 B2
6790496 Gustaf Sep 2004 B1
7100618 Dominguez Sep 2006 B2
7112712 Ancell Sep 2006 B1
7263282 Meyer Aug 2007 B2
7400940 McRae et al. Jul 2008 B2
7540286 Cross et al. Jun 2009 B2
7767698 Warchol Aug 2010 B2
7832410 Hon Nov 2010 B2
7992554 Radomski Aug 2011 B2
8156944 Hon Apr 2012 B2
8365742 Hon Feb 2013 B2
8375957 Hon Feb 2013 B2
8393331 Hon Mar 2013 B2
8430106 Potter Apr 2013 B2
8490628 Hon Jul 2013 B2
8511318 Hon Aug 2013 B2
8752545 Buchberger Jun 2014 B2
8689805 Hon Aug 2014 B2
8833364 Buchberger Sep 2014 B2
8948578 Buchberger Feb 2015 B2
9623205 Buchberger Apr 2017 B2
20010042546 Umeda Nov 2001 A1
20020016370 Shytle Feb 2002 A1
20020079309 Cox et al. Jun 2002 A1
20030005620 Ananth Jan 2003 A1
20030049025 Neumann et al. Mar 2003 A1
20030106552 Sprinkel, Jr. et al. Jun 2003 A1
20030200964 Blakley et al. Oct 2003 A1
20040031485 Rustad Feb 2004 A1
20040129793 Nguyen et al. Jul 2004 A1
20050204799 Koch Sep 2005 A1
20050268911 Cross et al. Dec 2005 A1
20060078477 Althouse Apr 2006 A1
20070014549 Demarest Jan 2007 A1
20070062548 Horstmann Mar 2007 A1
20070102013 Adams et al. May 2007 A1
20070107879 Radomski et al. May 2007 A1
20070155255 Galauner et al. Jul 2007 A1
20080092912 Robinson et al. Apr 2008 A1
20080216828 Wensley Sep 2008 A1
20080241255 Rose Oct 2008 A1
20090095311 Han Apr 2009 A1
20090188490 Han Jul 2009 A1
20090272379 Thorens et al. Nov 2009 A1
20090293892 Williams Dec 2009 A1
20100059070 Potter Mar 2010 A1
20100065653 Wingo Mar 2010 A1
20100083959 Siller Apr 2010 A1
20100108059 Axelson May 2010 A1
20100236546 Yamada et al. Sep 2010 A1
20110011396 Fang Jan 2011 A1
20110126848 Zuber et al. Jun 2011 A1
20110226236 Buchberger Sep 2011 A1
20110290267 Yamada et al. Dec 2011 A1
20110297166 Takeuchi et al. Dec 2011 A1
20110303231 Li et al. Dec 2011 A1
20120145169 Wu Jun 2012 A1
20120260927 Liu Oct 2012 A1
20130074857 Buchberger Mar 2013 A1
20130081623 Buchberger Apr 2013 A1
20130333700 Buchberger Dec 2013 A1
20140000638 Sebastian et al. Jan 2014 A1
20140060554 Collett et al. Mar 2014 A1
20140202454 Buchberger Jul 2014 A1
20140238396 Buchberger Aug 2014 A1
20140283825 Buchberger Sep 2014 A1
20140299125 Buchberger Oct 2014 A1
20140338680 Abramov Nov 2014 A1
20150114411 Buchberger Apr 2015 A1
20150208728 Lord Jul 2015 A1
20160073693 Reevell Mar 2016 A1
20160106154 Lord Apr 2016 A1
20160106155 Reevell Apr 2016 A1
20170042245 Buchberger Feb 2017 A1
20170197043 Buchberger Jul 2017 A1
20170197044 Buchberger Jul 2017 A1
20170197046 Buchberger Jul 2017 A1
Foreign Referenced Citations (102)
Number Date Country
507187 Mar 2010 AT
508244 Dec 2010 AT
510405 Apr 2012 AT
6393173 Jun 1975 AU
2309376 Nov 2000 CA
698603 Sep 2009 CH
2092880 Jan 1992 CN
2220168 Feb 1996 CN
2719043 Aug 2005 CN
201238609 May 2009 CN
201375023 Jan 2010 CN
202172846 Mar 2012 CN
102655773 Sep 2012 CN
202722498 Feb 2013 CN
202750708 Feb 2013 CN
106102863 Nov 2016 CN
1950439 Apr 1971 DE
3148335 Jul 1983 DE
3218760 Dec 1983 DE
3936687 May 1990 DE
19630619 Feb 1998 DE
19654945 Mar 1998 DE
10330681 Jun 2004 DE
202006013439 Oct 2006 DE
202013100606 Feb 2013 DE
280262 Aug 1989 EP
0358002 Mar 1990 EP
0358114 Mar 1990 EP
0488488 Jan 1991 EP
0444553 Sep 1991 EP
0845220 Jun 1998 EP
0295122 Dec 1998 EP
0893071 Jan 1999 EP
1166814 Jan 2002 EP
1736065 Dec 2006 EP
1950439 Jul 2008 EP
2018886 Jan 2009 EP
2022349 Feb 2009 EP
2113178 Nov 2009 EP
2340729 Jul 2011 EP
2698070 Feb 2014 EP
2762019 Aug 2014 EP
2835062 Feb 2015 EP
960469 Apr 1950 FR
25575 Jan 1912 GB
1313525 Apr 1973 GB
1196511 Dec 2014 HK
1226611 Oct 2017 HK
S57-052456 Mar 1982 JP
S59-106340 Jan 1986 JP
S61-096763 May 1986 JP
61-096765 Jan 1988 JP
H02-124081 Nov 1990 JP
H5-103836 Apr 1993 JP
H05-309136 Nov 1993 JP
H6-315366 Nov 1994 JP
8299862 Nov 1996 JP
H8-511176 Nov 1996 JP
H1189551 Apr 1999 JP
2002-527153 Apr 2000 JP
2004332069 Nov 2004 JP
2005-537919 Dec 2005 JP
2005-538159 Dec 2005 JP
2009-509523 Mar 2009 JP
2009-537119 Oct 2009 JP
2011-518567 Jun 2011 JP
2005-537918 Dec 2015 JP
2311859 Dec 2007 RU
2336001 Oct 2008 RU
89927 Dec 2009 RU
94815 Jun 2010 RU
WO9527412 Oct 1995 WO
WO9632854 Oct 1996 WO
WO9748293 Dec 1997 WO
WO0009188 Feb 2000 WO
WO0021598 Apr 2000 WO
WO2002058747 Aug 2002 WO
WO03028409 Apr 2003 WO
WO03050405 Jun 2003 WO
WO2003083283 Oct 2003 WO
WO2003101454 Dec 2003 WO
WO2004022242 Mar 2004 WO
WO2004022243 Mar 2004 WO
WO2005106350 Nov 2005 WO
WO2006082571 Aug 2006 WO
WO2007042941 Apr 2007 WO
WO2007131449 Nov 2007 WO
WO2009015410 Feb 2009 WO
WO2009132793 Nov 2009 WO
2010045671 Apr 2010 WO
WO2010045670 Apr 2010 WO
WO2011109849 Sep 2011 WO
WO2012025496 Mar 2012 WO
WO2013034453 Mar 2013 WO
WO2013034460 Mar 2013 WO
WO2013057185 Apr 2013 WO
WO2013098395 Jul 2013 WO
WO2013116558 Aug 2013 WO
WO2014130695 Aug 2013 WO
WO2014140320 Sep 2014 WO
WO2014150131 Sep 2014 WO
WO 2013082173 Oct 2014 WO
Non-Patent Literature Citations (44)
Entry
Application and File History for U.S. Appl. No. 13/984,512, filed Aug. 29, 2013, inventor Buchberger.
International Search Report and Written Opinion ((Machine Translation), dated Jul. 3, 2012 for International Patent Application No. PCT/AT2012/000017, filed Feb. 2, 2012. [Previously cited by or submitted to USPTO in U.S. Appl. No. 13/984,512, filed Aug. 29, 2013].
Written Opinion (WIPO English Translation), dated Jul. 3, 2012 for International Patent Application No. PCT/AT2012/000017, filed Feb. 2, 2012. [Previously cited by or submitted to USPTO in U.S. Appl. No. 13/984,512, filed Aug. 29, 2013].
International Preliminary Report on Patentability (WIPO English Translation), dated Aug. 13, 2013 for International Patent Application No. PCT/AT2012/000017, filed Feb. 2, 2012.
Application and File History for U.S. Appl. No. 14/235,210, filed Mar. 4, 2014, inventor Buchberger.
Kynol, Standard Specifications of Kynol Activated Carbon Fiber Products, published by Kynol. Date unknown.
International Search Report dated Jan. 26, 2010 for International Application No. PCT/AT2009/000414.
Japanese Notice of Reasons for Rejection for Japanese Application No. 2015-137361 dated May 31, 2016. English Translation Provided.
IPRP dated May 1, 2014 for International Patent Application No. PCT/EP2012/070647 filed Oct. 18, 2012.
International Search Report and Written Opinion dated Feb. 6, 2013 for PCT/EP2012/070647 filed Oct. 18, 2012.
International Search Report and Written Opinion for PCT/GB2014/051333 dated Jul. 17, 2014.
IPRP dated Aug. 5, 2015 for International Application No. PCT/GB2014/051333.
International Search Report and Written Opinion, International Application No. PCT/GB2014/051334 dated Jul. 21, 2014.
International Search Report and Written Opinion, International Application No. PCT/GB2014/051332 dated Jul. 21, 2014.
IPRP, International Application No. PCT/GB2014/051334 dated Nov. 12, 2015.
IPRP, International Application No. PCT/GB2014/051332 dated Nov. 12, 2015.
International Search Report and Written Opinion for International Application No. PCT/EP2012/003103 dated Nov. 26, 2012.
Application and File History for U.S. Appl. No. 14/353,256, filed Apr. 12, 2014, inventor Buchberger.
Application and File History for U.S. Appl. No. 14/594,065, filed Jan. 9, 2015, inventor Buchberger.
Application and File History for U.S. Appl. No. 13/125,343, filed Apr. 21, 2011, inventor Buchberger.
Application and File History for U.S. Appl. No. 15/307,095, filed Oct. 27, 2016, inventors Buchberger et al.
International Search Report for corresponding International Application No. PCT/GB2015/051213 dated Jul. 16, 2015; 5 pages.
Written Opinion of the International Searching Authority for corresponding International Application No. PCT/GB2015/051213 dated Jul. 16, 2015; 9 pages.
International Preliminary Report on Patentability for corresponding International Application No. PCT/GB2015/051213 dated Jul. 14, 2016; 21 pages.
Chinese Office Action, Chinese Application No. 201480024988.3, dated Dec. 30, 2016, 9 pages (17 pages with translation).
Chinese Office Action, Chinese Application No. 201480024988.3, dated Sep. 11, 2017, 7 pages (10 pages with translation).
Russian Office Action, Russian Application No. 2014120213, dated Oct. 26, 2016, 7 pages.
Dunn P And Reay D, Heat Pipes, 4th edition, 1994, ISBN 0080419038.
Rudolph G, BAT Cigarettenfabriken GmbH, 1987, The Influence of CO2 on the Sensory Characteristics of the Favor-System, http://legacy.library.ucsf. edu/tid/sla5lf00.
Japanese Notice of Reasons for Rejection, dated Sep. 8, 2015 for Japanese Application No. 2014179732.
Japanese Notice of Reasons for Rejection, dated Oct. 15, 2013 for Japanese Application No. 2011532464.
European Search Report for European Application No. 16166656 dated Oct. 11, 2016.
Notice of Opposition Letter from EPO. Opposition against EP2358418 dated Mar. 1, 2017.
International Search Report for International Application No. PCT/AT2009/000413 dated Jan. 25, 2010.
Chinese First Office Action for Chinese Application No. 200980152395.4 dated Dec. 3, 2012.
Chinese Second Office Action for Chinese Application No. 200980152395.4 dated Aug. 20, 2013.
Russian Decision to Grant, Application No. 2011120430/14, dated Apr. 1, 2014, 10 pages.
Japanese Search Report, Application No. 2016-134648, dated Apr. 14, 2017, 11 pages.
Japanese Search Report, Application No. 2014-179732, dated Sep. 9, 2015, 5 pages.
Japanese Search Report, Application No. 2011-532464, dated Sep. 24, 2013, 73 pages.
Japanese Decision to Grant, Application No. 2011-532464, dated Aug. 5, 2014, 3 pages.
European Extended Search Report, Application No. 17189951.1, dated Jan. 4, 2018, 8 pages (11 pages with translation).
Pulmonary Pharmacology: Delivery Devices and Medications, accessed at www.cdeu.org/cecourses/z98207/ch4.htm, dated Sep. 6, 2017.
Kynol, Standard Specifications of Activated Carbon Fiber Products, published by Kynol, date unknown.
Related Publications (1)
Number Date Country
20140238396 A1 Aug 2014 US
Continuations (1)
Number Date Country
Parent 13984512 US
Child 14268909 US